MedTrace Logo

Simulating Psychotherapeutic Sessions With Generative Artificial Intelligence

NCT06813066 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 520

Last updated 2026-05-22

No results posted yet for this study

Summary

The study assesses the potential of using computational models, specifically large language models, to simulate psychotherapeutic sessions, aiming to improve therapy outcomes and advance therapist training through innovative technology.

Conditions

  • Mental Disorder

Interventions

BEHAVIORAL

High Levels of Common Therapeutic Factors

The therapist large language model (LLM) is designed to show high levels of empathy, warmth, and genuineness. This setup aims to create a supportive and trusting therapeutic environment to improve patient engagement. High levels of these positive factors are linked to better psychotherapy outcomes and a stronger therapist-patient relationship.

BEHAVIORAL

Low Levels of Common Therapeutic Factors

The therapist LLM for this group is designed to show low levels of empathy, warmth, and genuineness. This setup aims to examine how a less supportive and empathetic therapist affects psychotherapy sessions. Lower levels of these positive behaviors can lead to reduced patient engagement and a weaker therapist-patient relationship, potentially hindering therapy outcomes.

BEHAVIORAL

Standard motivational interviewing

Motivational interviewing techniques as applied during the sessions on which the transcripts are based.

Sponsors & Collaborators

  • University of Trier

    collaborator OTHER

  • RWTH Aachen University

    collaborator OTHER

  • University of Basel

    collaborator OTHER

  • University Hospital, Basel, Switzerland

    lead OTHER

Principal Investigators

  • Gunther Meinlschmidt, Prof. Dr. · University Hospital and University of Basel

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-02-01
Primary Completion
2025-08-31
Completion
2025-08-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06813066 on ClinicalTrials.gov